BridgeMD
New treatment option for Stroke
Official title fNIRS-Driven Visual Feedback Training to Restore Walking After Stroke
ClinicalTrials.gov ID: NCT07014891
What this study is testing
- What it's testing
- The objective of this clinical trial is to investigate whether intelligent visual feedback-based lower limb motor control training is more effective than conventional rehabilitation training in promoting walking ability recovery among stroke patients with hemiplegia. The trial aims to address the primary question of the impact of intelligent visual feedback motor control training on the walking function of stroke patients with hemiplegia, and uses three-dimensional gait analysis for precise quantitative evaluation of therapeutic effects.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- 1: Vital signs are stable, with no severe cardiopulmonary diseases, making the patient suitable for exercise testing.
- 2: All patients are diagnosed with stroke by head CT or MRI, with clinical manifestations of unilateral limb hemiplegia.
- 3: The Brunnstrom stage of the lower limb is 3-5, quadriceps muscle strength is ≥ grade 3, modified Ashworth scale for the lower limb is \< grade 2...
- 4: This is their first onset of the disease, with a disease course of ≤ 6 months, and the condition is stable.
- 5: Patients have no severe cognitive impairment or sensory aphasia, can understand and actively participate in the training program, and have...
You likely can't join if
- 1: Patients with tumors, tuberculosis, hematological diseases, or functional impairments of vital organs such as the heart or liver.
- 2: Those with lower limb musculoskeletal disorders, such as knee arthritis or lower limb fractures.
- 3: Individuals with severe abnormal muscle tone in the limbs or joint contracture deformities.
- 4: Patients experiencing severe pain that prevents them from tolerating physical activity.
- 5: Special populations, such as individuals with mental illnesses, breastfeeding women, or pregnant women.
See the full eligibility criteria
- 1: Vital signs are stable, with no severe cardiopulmonary diseases, making the patient suitable for exercise testing.
- 2: All patients are diagnosed with stroke by head CT or MRI, with clinical manifestations of unilateral limb hemiplegia.
- 3: The Brunnstrom stage of the lower limb is 3-5, quadriceps muscle strength is ≥ grade 3, modified Ashworth scale for the lower limb is \< grade 2, and Hoffer walking scale is ≥ grade 2.
- 4: This is their first onset of the disease, with a disease course of ≤ 6 months, and the condition is stable.
- 5: Patients have no severe cognitive impairment or sensory aphasia, can understand and actively participate in the training program, and have provided informed consent by signing the consent form for this clinical study.
- 6: Age: 18-75 years old, no gender restrictions.
- 1: Patients with tumors, tuberculosis, hematological diseases, or functional impairments of vital organs such as the heart or liver.
- 2: Those with lower limb musculoskeletal disorders, such as knee arthritis or lower limb fractures.
- 3: Individuals with severe abnormal muscle tone in the limbs or joint contracture deformities.
- 4: Patients experiencing severe pain that prevents them from tolerating physical activity.
- 5: Special populations, such as individuals with mental illnesses, breastfeeding women, or pregnant women.
The study team makes the final eligibility decision.
Where it's taking place
- Shenyang, Liaoning, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shenyang, Liaoning, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.